Michael Ciesielski Email Address
@roswellpark.org
Chief Executive Officer and MimiVax
Roswell Park Comprehensive Cancer Center in Buffalo, NY brings together the best minds in cancer care who are dedicated to our mission to understand, prevent and cure cancer.
MimiVax, LLC is accelerating the development of SurVaxM vaccine for cancer through continued clinical research and pharmaceutical partnerships. Phase II trials of SurVaxM for newly diagnosed glioblastoma are now open and recruiting at Roswell Park Cancer Institute and the Cleveland Clinic. MimiVax is dedicated to bring cutting edge science to the bedside, providing hope and improved quality of life for cancer patients. Dr. Ciesielski is a co-founder of MimiVax, LLC and holder of several global patents for the anti-cancer survivin vaccine (SurVaxM) technology. MimiVax is a spin-out company of Roswell Park Cancer Institute formed to bring novel immunotherapeutic agents for anticancer therapy from the bench to the bedside. -Extensive experience in experimental neuro-oncology, immunology, pre-clinical design and clinical translation. -Exploring the protective efficacy of immunotherapy against intracranial glioma, as well as molecular targeting modalities. -Authored more than 42 journal articles and reviews. -Served as a member of NIH-NCI, VA and Komen for the Cure research study sections. -Active member of the Society for Neuro-Oncology and American Association for Cancer Research as well as a reviewer for numerous scientific journals.
Other people working at RPCCC:
How does this work?
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you're looking to find the email of Michael Ciesielski at RPCCC then you've come to the right place.
Wondering if it's michael@roswellpark.org, michael.ciesielski@roswellpark.org, ciesielski@roswellpark.org, or mciesielski@roswellpark.org? We have the answers for you.